DSP Healthcare Fund Regular Growth is a Sector - Healthcare mutual fund scheme from DSP Asset Managers Private Limited. The fund was launched on 30 November 2018 and is managed by Chirag Dagli. As of 9 October 2026, the fund has an AUM of ₹3,835.28 Cr and its latest NAV is ₹44.05. The fund has a Very High Risk risk rating.
The fund allows minimum SIP of ₹100 and lumpsum investment starting from ₹100.
The fund primarily invests in Healthcare, Financial Services, and Technology and its top holdings include Ipca Laboratories Ltd, Sun Pharmaceuticals Industries Ltd, Illumina Inc, Sai Life Sciences Ltd, and Cipla Ltd. The fund has delivered 12.8% returns over the last 1 year, 19.1% annualised returns over 3 years, 13.6% annualised returns over 5 years, and 20.8% annualised returns since inception.
DSP Healthcare Fund Regular Growth may be suitable for investors looking for Sector - Healthcare and who are comfortable with Very High Risk risk.






